Biomonitoring Equivalents for glyphosate.

Biomonitoring Biomonitoring equivalents Exposure assessment Glyphosate Risk assessment

Journal

Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295
Titre abrégé: Regul Toxicol Pharmacol
Pays: Netherlands
ID NLM: 8214983

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 09 06 2023
revised: 09 08 2023
accepted: 22 08 2023
pubmed: 27 8 2023
medline: 27 8 2023
entrez: 26 8 2023
Statut: ppublish

Résumé

One of the most widely used herbicides worldwide, glyphosate is registered for use in many agricultural and non-agricultural settings. Accordingly, regulatory authorities develop toxicology reference values (TRVs) to conduct risk assessments for potential exposures. Exposures to glyphosate are typically biomonitored via measures of glyphosate in urine. However, measured concentrations of glyphosate in urine, with units mg/L urine, cannot be directly interpreted using the available TRVs as they are presented in terms of daily intake levels (e.g. mg/kg-bw per day). In this evaluation, we review available health-based risk assessments and TRVs for glyphosate and derive Biomonitoring Equivalent (BE) values for interpretation of population biomonitoring data. Biomonitoring Equivalents (BEs) are defined as the concentration or range of concentrations of a chemical or its metabolite in a biological medium (blood, urine, human milk, etc.) that is consistent with an existing health-based TRVs such as a reference dose (RfD) or tolerable daily intake (TDI). The BE values derived in this manuscript are screening values that can help public health officials and regulators interpret glyphosate biomonitoring data.

Identifiants

pubmed: 37633328
pii: S0273-2300(23)00149-6
doi: 10.1016/j.yrtph.2023.105481
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105481

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest All authors have no interests that would influence or bias their opinions as expressed in this manuscript.

Auteurs

Sean M Hays (SM)

Summit Toxicology, LLC, Bozeman, MT, USA. Electronic address: shays@summittoxicology.com.

Christopher R Kirman (CR)

Summit Toxicology, LLC, Bozeman, MT, USA.

Jennifer Flippin (J)

Tetra Tech, Inc, Denver, CO, USA.

Theresa Lopez (T)

Tetra Tech, Inc, Denver, CO, USA.

Classifications MeSH